Several novel functionalized adamantyl aryl- and heteroarylpiperazine derivatives were prepared and examined in various receptor binding and behavioral tests to determine their serotonin receptor activities. Many compounds demonstrated modest to high affinity for 5-HT(1A) receptors, with compounds 9, 13, 23, 33, 34, and 43 being the most potent at this site. Compound 1, 2-[4-(2-pyrimidinyl)-1-piperazinyl]ethyl adamantyl-1-carboxylate, demonstrated relatively high affinity for 5-HT(1A) receptors (K(i) = 8 nM) and acceptable selectivity versus D(2) receptors (K(i) = 708 mM); however, it lacked in vivo activity in serotonergic behavioral models. In contrast, compounds 9 (WY-50,324, SEB-324, adatanserin), adamantyl-1-carboxylic acid 2-[4-(2-pyrimidinyl)-1-piperazinyl]ethylamide, and 13, adamantyl-1-carboxylic acid 2-[4-(2-methoxyphenyl)-1-piperazinyl]ethylamide, demonstrated high affinity for 5-HT(1A) binding sites (K(i) = 1 nM for both) and moderate affinity for 5-HT(2) receptors (K(i) = 73 and 75 nM, respectively). Both compounds also demonstrated partial 5-HT(1A) agonist activity in vivo in rat serotonin syndrome and 5-HT(2) antagonist activity in quipazine- and DOI-induced head shake paradigms. The selective 5-HT(1A) partial agonist and 5-HT(2) antagonist activity of 9 was accompanied by significant anxiolytic activity in an animal conflict model. On the basis of this profile, compound 9 entered development as a combined anxiolytic and antidepressant agent.
Cerebral ischemia was induced in Mongolian gerbils by bilateral occlusion of the carotid arteries. Subsequent histological assessment revealed neuronal degeneration in the CA1 area of the hippocampus. A functional behavioral change was reflected in an elevation of motor activity compared with sham-operated animals. The degree of hippocampal damage was positively correlated with the increase in motor activity. It is concluded that alterations in both measures result from the interruption of blood flow to the brain but may be brought about by different mechanisms.
Key words: phospholipid labeling effect --hippocampus --muscarinic --cholinergic inputThe enhanced incorporation of 32Pi into two minor acidic phospholipids, phosphatidate and phosphatidylinositol, is a response characteristic of a number of effectors, including neurotransmitters and hormones, with their receptors on the cell membrane. In the nervous system, this is perhaps best documented in the case of acetylcholine action on brain synaptosomes, slices or on sympathetic ganglia (for review, see ref. 14). This 'phospholipid labeling effect' (PLE) appears to require tissue structural integrity since it is not observed in cell-free preparations. The PLE elicited by muscarinic agonists in nerve ending fractions 19 might be considered an exception. However, isolated synaptosomes retain considerable internal structure and metabolic viability, and as such may be considered as resealed anucleate neurons. Neurotransmitter receptors have traditionally been considered to be localized on the postsynaptic membrane, and a number of indirect approaches suggest that the neurotransmitter-directed PLE in pineal gland 21 and superior cervical ganglion 11 is associated with this site. In the case of synaptosomes, this conclusion is not readily made. For example, the assumption that added azPi must first be converted to y-32P-ATP before phospholipids can be labeled suggests that intrasynaptosomal oxidative phosphorylation is an obligate step in the synaptosomal PLE (see ref. 19), an argument that would appear to favor a presynaptic localization. Furthermore, postsynaptic membranes are not prominent in the 'light' synaptosomal fraction shown to mediate the PLE in guinea pig brain fractions 2°. The case for a presynaptic site is however by no means conclusive. In a recent study, we concluded that calcium mobilization accompanies the muscarinic PLE (see ref. 5) in synaptosomes. The increase in calcium availability that parallels the PLE is at variance with the probable physiological role of presynaptic muscarinic receptors in cerebral cortex in reducing neurotransmitter release 1~,z2. by appearing to limit calcium availability 13. That is, we would have anticipated that ac-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.